Overview

  • Product name
    Recombinant HIV1 p17 protein
  • Protein length
    Full length protein

Description

  • Nature
    Recombinant
  • Source
    Escherichia coli

Specifications

Our Abpromise guarantee covers the use of ab63981 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

  • Purity
    > 90 % SDS-PAGE.

  • Form
    Liquid
  • Additional notes
    ab63981 has been derived from infectious plasmid clone pNL4-3 and belongs to Group B of HIV-1.
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.

    Preservative: None
    Constituents: 50% Glycerol, 50mM Sodium chloride, 20mM Tris HCl, 10mM Beta mercaptoethanol, pH 7.5

General Info

  • Alternative names
    • HIV1 matrix protein p17
    • HIV1 p17
    • MA
    • Matrix protein p17
  • Relevance
    HIV1 p17 is the matrix protein of the Gag polyprotein which performs highly complex orchestrated tasks during the assembly, budding, maturation, and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA.
  • Cellular localization
    Matrix protein of HIV1 Gag polyprotein

Recombinant HIV1 p17 protein images

  • Polyacrylamide gel electrophoresis of ab63981.

References for Recombinant HIV1 p17 protein (ab63981)

ab63981 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab63981.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up